Fortekor Palatable Tablets 2.5 mg (56 tablets)
For Treatment of heart failure in dogs and treatment of chronic renal insufficiency in cats Read more
For Treatment of heart failure in dogs and treatment of chronic renal insufficiency in cats
Visit www.myvetmeds.co.uk / dog / heart-breathing-dog / fortekor-palatable-tablets-2-5-mg.htm
Product Description
About Fortekor Palatable Tablets 2.5 mg (56 tablets)
For Treatment of heart failure in dogs and treatment of chronic renal insufficiency in cats
Please note: images are for illustration purposes only and pack sizes/strengths and new packaging styles may not be reflected in the image shown.
Directions For Use
Directions for Use
For oral use only. Fortekor should be given orally once daily, with or without food. The duration of treatment is unlimited.
In dogs, the recommended oral dose is 0.25-0.5mg benazepril hydrochloride/kg body, given according to the following regime:
FORTEKOR 2.5
Weight of Animal
Standard Dose( Double Dose)
2.5 - < 5 kg
0.5 tablet (1 tablet)
5 ? 10
1 tablet (2 tablets)
The dose may be doubled, still administered once daily, if judged clinically necessary and advised by the veterinary surgeon.
In cats, FORTEKOR should be administered orally at a dose of 0.5-1.0 mg benazepril hydrochloride/kg body weight, once daily according to the following table:
2.5 ? 5 kg 1 tablet
>5 ? 10kg 2 tablets
Active Ingredient
Fortekor Palatable Tablets 2.5 mg (56 tablets) ingredients
Active substance: Benazepril hydrochloride 2.5 mg
Side Effects
Side effects of Fortekor Palatable Tablets 2.5 mg (56 tablets)
In double-blind clinical trials in dogs with heart failure, FORTEKOR was well tolerated with an incidence of adverse effects statistically lower than observed in placebo treated dogs. A small number of dogs may exhibit transient signs of fatigue or dizziness.
In cats with chronic renal insufficiency, FORTEKOR may increase plasma creatinine concentrations at the start of therapy. This effect is related to the therapeutic effect of the product in reducing blood pressure, and therefore is not necessarily a reason to stop therapy in the absence of other signs. As is routine in cases of chronic renal insufficiency, it is recommended to monitor plasma creatinine during therapy.
FORTEKOR reduced erythrocyte counts in normal cats at high doses, but this effect was not observed at the recommended dose during clinical trials in cats with chronic renal insufficiency. As is routine in cases of chronic renal insufficiency, it is recommended to monitor erythrocyte counts during therapy.
FORTEKOR may increase food consumption and body weight in cats. Emesis, anorexia and lethargy have been reported very rarely in this species.
Additional Data
Fortekor Palatable Tablets 2.5 mg (56 tablets) specification
| Specification: | Detail: |
|---|---|
| Associated Documents: |
Click here to preview |
| Pack Size: | 56 tablets |
| Brands: | Novartis Animal Health |
| Product Form: | tablet |
| Strength/Size: | 2.5 mg |
